Nymirum Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 2

Nymirum General Information

Description

Developer of an RNA-targeting small molecule discovery platform designed to resolve and leverage RNA's dynamic structure. The company's proprietary platform combines the speed and scope of advanced in silico technologies with the rigor and validation of experimental methods to unlock the potential of RNA targets across all therapeutic areas, thereby enabling the healthcare industry to build transformative medicine.

Contact Information

Website
www.nymirum.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Primary Office
  • 4324 South Alston Avenue
  • Suite 110
  • Durham, NC 27713
  • United States

Nymirum Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nymirum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jul-2021 00.00 Completed Generating Revenue
2. Grant 01-Jan-2018 00.00 00.00 Completed Generating Revenue
1. Early Stage VC (Series A) 21-May-2009 $1.1M $1.1M 00.00 Completed Startup
To view Nymirum’s complete valuation and funding history, request access »

Nymirum Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00 00.000
To view Nymirum’s complete cap table history, request access »

Nymirum Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an RNA-targeting small molecule discovery platform designed to resolve and leverage RNA's dynamic structure
Biotechnology
Durham, NC
10 As of 2021
00.00
00000000000 00.00

0000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
0000 000000000
Waltham, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000000

empor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitatio
0000000000000
Waltham, MA
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nymirum Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrakis Therapeutics Venture Capital-Backed Waltham, MA 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Waltham, MA 000 00000 0000000000 0 00000
You’re viewing 2 of 2 competitors. Get the full list »

Nymirum Executive Team (4)

Name Title Board Seat Contact Info
Joshua Fairbank Co-Founder, Chief Executive Officer & Chairman
Hashim Al-Hashimi Ph.D Co-Founder & Platform Architect
Michael Pape Ph.D Co-Founder, Director of Drug Development & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Nymirum Board Members (3)

Name Representing Role Since
Edward Chandler Self Board Member 000 0000
Joshua Fairbank Nymirum Co-Founder, Chief Executive Officer & Chairman 000 0000
Michael Pape Ph.D Self Co-Founder, Director of Drug Development & Board Member 000 0000
To view Nymirum’s complete board members history, request access »

Nymirum Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nymirum Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Nymirum’s complete investors history, request access »